John Libertino — Burlington, Massachusetts

John Libertino is a clinical research site located in Burlington, Massachusetts, United States.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

John Libertino has participated in 1 clinical trials.

Therapeutic areas: Carcinoma in Situ, Bladder Cancer.

Sponsors: Endo Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for John Libertino?

John Libertino has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has John Libertino conducted?

John Libertino has 1 clinical trials on record. Their work covers Carcinoma in Situ, Bladder Cancer.

Is John Libertino accredited by Crixeo Health?

John Libertino has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about John Libertino?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.